Melatonin and agomelatine for preventing seasonal affective disorder-Reference-Cited by-同舟云学术

Melatonin and agomelatine for preventing seasonal affective disorder

Published:2019-06-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Nussbaumer-Streit Barbara¹,Greenblatt Amy²,Kaminski-Hartenthaler Angela³,Van Noord Megan G⁴,Forneris Catherine A⁵,Morgan Laura C⁶,Gaynes Bradley N⁵,Wipplinger Jörg³,Lux Linda J⁷,Winkler Dietmar⁸,Gartlehner Gerald¹⁷

Affiliation:

1. Danube University Krems; Cochrane Austria, Department for Evidence-based Medicine and Clinical Epidemiology; Dr.-Karl-Dorrek-Str. 30 Krems Austria 3500

2. Emory University; Nell Hodgson Woodruff School of Nursing; Atlanta Georgia USA

3. Danube University Krems; Department for Evidence-based Medicine and Clinical Epidemiology; Dr.-Karl-Dorrek-Strasse 30 Krems Austria 3500

4. University of California Davis; Carlson Health Sciences Library; Davis California USA

5. University of North Carolina at Chapel Hill; Department of Psychiatry; 101 Manning Dr., CB# 7160 Chapel Hill North Carolina USA 27599-7160

6. IBM Watson Health; 15 Dartford CT Chapel Hill North Carolina USA 27517

7. RTI International; 3040 Cornwallis Road Research Triangle Park North Carolina USA 27709

8. Medical University of Vienna; Department of Psychiatry and Psychotherapy; Waehringer Guertel 18-20 Vienna Austria 1090

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011271.pub3/epdf/full

Reference60 articles.

1. European Medicines Agency CHMP Assessment Report for Thymax. [Procedure No. EMEA/H/C/000916] www.ema.europa.eu/en/documents/assessment-report/thymanax-epar-public-assessment-report_en.pdf 2008

2. Kasper S Lam R Partonen TT Moller HJ den Boer J Magnusson A Efficacy and safety of S 20098 (25 mg) in the prevention of recurrence, in patients with a seasonal affective disorder, treated once a day for 1 year after an open period of at least 18 weeks. A randomised, double-blind, placebo-controlled, parallel group study [CL3-20098-037] Institut de Recherches Internationales Servier (I.R.I.S.) 2008 1-131 [Confidential]

3. Mindfulness-based cognitive therapy for seasonal affective disorder: A pilot study;Fleer;Journal of Affective Disorder,2014

4. Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial;Goodwin;Journal of Clinical Psychiatry,2009

5. Leppämäki S Partonen T Vakkuri O Lönnqvist J Partinen M Laudon M Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour European Neuropsychopharmacology 2003 137 45

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases;Life Sciences;2024-05

2. Therapeutic potential of melatonin in targeting molecular pathways of organ fibrosis;Pharmacological Reports;2023-11-23

3. An update on pharmacotherapy for recurrent depression in 2022;Expert Opinion on Pharmacotherapy;2023-06-19

4. Night shift hormone: How does melatonin affect depression?;Physiology & Behavior;2022-08

5. When is pharmacotherapy necessary for the treatment of seasonal affective disorder?;Expert Opinion on Pharmacotherapy;2022-07-12